Photo of Professor Greg Shaw

Professor Greg Shaw

Telephone:

Email:

Location:

  • University College Hospital at Westmoreland Street

GMC/GDC number:

4626222

Professional background

Current posts:

  • Professor of Urology (2022)
  • Lead for Robotic Urology, UCLH, (2020 to date)
  • Consultant urologist, UCLH (2015 to date)

Current positions:

  • Royal College of Surgeons of England- Research Consultant (March 2021 – to date)
  • National Institute of Health Research, Lead for Urology, North Thames (2016 – to date)
  • London Cancer- Lead for Research, (2015 to date)
  • Associate Editor Uro-oncology- British Journal of Urology International Knowledge. (2015 to date)
  • National Cancer Research Network, Clinical Studies Group member, (2016 to date)

Former positions:

  • Royal College of Surgeons Fellow in Robotic Surgery (2015-2016)
  • National Institute of Health Research- Clinical Lecturer (2010 - 2015)

Specialties

Research interests

  • Leading national Randomised controlled Trial – NeuroSAFE PROOF study- To evaluate the use of frozen section analysis during radical prostatectomy to promote nerve sparing and improve quality of life
  • Confocal microscopy to improve outcomes with urological surgery
  • Circulating tumour cells in prostate cancer
  • Use of MRI in planning robotic prostatectomy

Languages spoken

English and Italian

Publications

Ten most relevant publications:

Citation metrics (March 2021): 2008 citations overall. h-Index 26; i10-index 46

  1. Tandogdu Z.. Shaw G… Kelly J. Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus view. BJU Int. 2020 Nov 13. PMID: 33185026
  2. A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site. A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site. Kasivisvanathan, V...Wood, C. UCLH study group collaborators. International Journal of Surgery, 2020, 84, pp. 57-65 PMID: 33122153
  3. NeuroSAFE frozen section during robot-assisted radical prostatectomy (RARP): Peri-operative and Histopathological Outcomes from the NeuroSAFE PROOF Feasibility Randomised Controlled Trial. Eoin Dinneen, ..J Grierson, A Haider, A Freeman, and G Shaw. BJU Int. 2020 Sep 27. PMID: 32985121
  4. Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer L  Li , .., G Shaw, .. M Ladomery et al. Br J Cancer. 2020 Sep;123(6):1024-1032. PMID: 32581342
  5. Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins. B Rocco , ..G Shaw, S Nathan, S Micali , G Bianchi, A Maiorana , G Pellacani, R Montironi  BJU Int, 2020 Sep;126(3):336-338.  PMID: 32401370
  6. NeuroSAFE Technique - pathological considerations and practical implications to guide nerve-sparing surgery in prostate cancer patients. E Dinneen, A Hayder, GL Shaw, Histopathology. 2020 Oct;77(4):536-538. PMID: 32945017
  7. NeuroSAFE PROOF Randomised Controlled Feasibility Study:Brief Report of Perioperative outcomes, histological concordance and feasibility. E Dinneen, , GL Shaw Eur Urol. 2020 Sep;78(3):476-478. PMID: 32340693
  8. Intraoperative Frozen Section for margin evaluation during Radical Prostatectomy: A Systematic Review. Eoin Dinneen, MIchelle van der Slot, Kelvin Adasonla, Jin Tan, Jack Grierson, Aiman Haider, Alex Freeman, and Greg Shaw Eur Urol Focus. 2019 Nov 29. PMID: 31787570
  9. Non-invasive detection of clinically significant prostate cancer using circulating tumor cells. Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S, Stankiewicz E, Davies CR, Rajan P, Tipples K, Hines J, Chan PY, Campbell D, Wilkinson K,Kudahetti S, Shamash J, Oliver T, Berney D, Shaw G, Lu YJ. J Urol  2019 PMID: 31389764.
  10. Thompson JE, …Shaw GL, et al. Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound. J Urol. 2019;201(6):1134-43.